Qualitative immunoglobulin abnormalities in HIV-positive patients: Long-term follow-up

Clinical Chemistry and Laboratory Medicine

Volumn 36, Issue 7, 1998, Pages 493-496

  Pontet, Françoise ^a   Gué, Xavier ^a   Mazeron, Marie Christine ^a   Alain, Sophie ^a   Sanson Le Pors, Marie José ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Follow up; HIV; Immunoglobulin abnormalities

Indexed keywords

IMMUNOGLOBULIN; PARAPROTEIN; POLYCLONAL ANTIBODY;

ADULT; ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOELECTROPHORESIS; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGE DISTRIBUTION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; PROGNOSIS; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 0031664094     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1998.082     Document Type: Article

References (12)

1. Lefrère JJ, Debbia M, Lambin P. Prospective follow-up of monoclonal gammopathies in HIV-infected individuals. Br J Haematol 1993; 84:151-5.
2. Kouns DM, Marty AM, Sharpe RW. Oligoclonal bands in serum protein electrophoretograms of individuals with human immunodeficiency virus antibodies. J Am Med Ass 1986; 256 (17):2343.
3. Heriot K, Hallquist AE, Tomar RH. Paraproteinemia in patients with acquired immunodeficiency syndrome (AIDS) or lymphadenopathy syndrome (LAS). Clin Chem 1985; 31 (7):1224-6.
4. Sinclair D, Galloway E, McKenzie S, Follett EAC, Wallace L. Oligoclonal immunoglobulins in HIV infection. Clin Chem 1989; 35 (8):1669-71.
5. Pontet F, Gué X, Mazeron MC, Alain S, Sanson-Lepors MJ. Étude des dysglobulinémies monoclonales chez les patients VIH positifs: bilan du suivi après 10 ans [abstract]. L'Eurobiologiste 1996; XXX, 221:192.
6. Scheidegger JJ. Une microméthode de l'immunoélectrophorèse. Int Arch Allergy Appl Immunol 1955; 7:103-10.
7. Estève J, Benhamou E, Raymond L. Méthodes statistiques en épidémiologie descriptive. Paris: les éditions INSERM, 1993.
8. Kyle RA. Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma. Hematol Oncol Clin North Am 1997; 11:71-87.
9. Hurez D. Epidémiologie des gammapathies monoclonales. Rev Prat (Paris) 1993; 43 (3):271-4.
10. Blade J, Lopez-Guillermo A, Rozman C, Cervantes F, Salgado C, Aguilar JL, et al. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br J Haematol 1992; 81:391-4.
11. Carter A, Tatarsky I. The physiopathological significance of benign monoclonal gammopathy: a study of 64 cases. Br J Haematol 1980; 46:565-74.
12. Pontet F, Delauche-Cavallier MC. L'immunoglobuline monoclonale, marqueur tumoral du myélome et de la maladie de Waldenström. In: Girard ML, Rousselet F, Legrand A, editors. Aspects biologiques de la maladie cancéreuse. XXVIIèmes Dimanches Biologiques de Lariboisière; Apdila 1987.